Crossmark

Belimumab, una alternativa útil en el tratamiento de la serositis lúpica

Crossref DOI link: https://doi.org/10.1016/j.medcli.2020.06.034

Published Print: 2021-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Salman-Monte, Tarek Carlos

Carrión-Barberà, Irene

Rodríguez García, Eva
License Information

Text and Data Mining valid from 2021-09-01
More Information

This article is maintained by: Elsevier

Article Title: Belimumab, una alternativa útil en el tratamiento de la serositis lúpica

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2020.06.034

Content Type: simple-article

Copyright: © 2020 Elsevier España, S.L.U. All rights reserved.